GlassScriptPhysician profile
Alexander C Lapka
NPI 1851826671
$572.03
in general payments reported to CMS, 2019-2025
15 companies · $88.43 in 2025
The $88.43 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
See the full distribution for Sports Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.92 · 2020: $11.64 · 2021: $229 · 2022: $91.12 · 2023: $89.15 · 2024: $35.57 · 2025: $88.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tenex Health INC. | $115.16 | 2021 | |
| Ferring Pharmaceuticals INC. | $97.50 | 2021-2025 | Euflexxa |
| Orthofix Medical, INC. | $74.32 | 2022-2025 | Physio-Stim |
| Bioventus LLC | $58.21 | 2022-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $49.51 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $28.44 | 2022 | |
| Kci USA, INC. | $23.47 | 2023 | Activ.A.C. |
| Almatica Pharma LLC | $20.81 | 2021 | |
| Ethicon US, LLC | $18.78 | 2025 | Stratafix, Vistaseal |
| Solventum Corporation | $17.88 | 2025 | Activ.A.C. |
| Biohaven Pharmaceuticals, INC. | $16.24 | 2021 | |
| Avanos Medical | $13.95 | 2019 | |
| Dusa Pharmaceuticals, INC. | $12.97 | 2019 | |
| Horizon Therapeutics Plc | $12.69 | 2022 | |
| Abbvie INC. | $12.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Lapka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.